dvm360 Flex™ empowers learners with a 360-degree solution for flexible learning anytime, anywhere—in print, on-demand, live, and in person for convenient learning with you in mind!
Continuing education (CE) opportunities can be found on our online dvm360 Flex™ platform.
Oral and dental pain can result from various diseases, as well as any surgical intervention. Acquired diseases such as periodontal disease, fractured teeth and tooth resorption can lead to discomfort. Management of oral and dental disease, as well as a comprehensive, multimodal analgesic protocol, can keep our patients comfortable and return them to health and function through optimal healing
To view this webinar, go here.
This webinar will discuss the anatomy of the feline as it pertains to orthopedic disease. Common causes of thoracic and pelvic limb lameness in cats will be presented along with associated treatment methods. Particular attention will be taken in discussing treatment of feline osteoarthritis.
To view this webinar, go here.
This course will cover an introduction to microbiome medicine. We will discuss the concept of microbiome medicine and review examples including antibiotics, probiotics, prebiotics, phage therapy, and fecal microbiota transplantation. We will discuss how veterinarians can evaluate the intestinal microbiome of their patients and its clinical utility. We will discuss in detail microbiome therapeutics and review evidence-based examples for small animal practice.
To view this webinar, go here.
In this webinar, we look at the complete journey to start a new veterinary business from scratch. Every step: from the business planning to the administrative setup, the tools of the trade, the recruitment and marketing, and the bumps in the road.
To view this webinar, go here.
The goal of a spectrum of care approach to veterinary practice is to empower pet families to access pet health care that best fits their expectations and financial considerations.
Register for this webinar here.
Once a test has been validated and is commercially available, it is important for the laboratory to periodically report utilization and performance metrics regarding the test. Blood-based liquid biopsy using next-generation sequencing became clinically available in May 2021. Since that time, the test has been ordered for thousands of patients, primarily as a screening tool for dogs at higher risk of cancer, and as an aid in diagnosis for dogs for which there is a clinical suspicion of cancer. This session will review data from a cohort of 1,500 consecutive liquid biopsy tests received for commercial testing at one clinical laboratory, and will include a discussion of ordering patterns, positivity rates, and patient outcome data, along with how this data can be used to discuss liquid biopsy testing with clients. A series of interesting case studies will be presented, exploring the use of this testing in a variety of clinical settings.
Register for this webinar here.